PFE vs REPX · P/E 20, rev $62.58B vs P/E 12, rev $410.2M
Pfizer Inc (PFE) versus Riley Exploration Permian Inc (REPX) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Riley Exploration Permian Inc (REPX) is a oil & gas e&p company listed on AMEX.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported REPX revenue for 2024-12-31 was $410.2M. Net income was $88.9M. Revenue was up 9.4% from 2023-12-31 to 2024-12-31. REPX currently screens at market cap $727.0M and trailing P/E 11.7.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. REPX currently screens at market cap $727.0M and trailing P/E 11.7.
Not investment advice. Open the PFE and REPX stock pages for the full models.
Not investment advice.